Houston leads U.S. with this aggressive strategy to lure top talent, says new survey

JOBS, JOBS, JOBS

More full-time jobs are on the way to Houston. Photo by Edmond Dantès via Pexels

Many employers in Houston are ready to field new full-time employee applicants — and are ready to aggressively sweeten the deal.

New survey data from staffing firm Robert Half shows 50 percent of companies in Houston plan to add new full-time jobs in the second half of 2021. That's right on pace nationally; the number was 51 percent. Managers at companies with at least 20 employees participated in the survey.

Among the 28 U.S. cities in the Robert Half survey, those with the highest percentage of employers who expect to staff up this year are San Diego (62 percent), Dallas (61 percent), and Atlanta and Los Angeles (58 percent each).

Elsewhere in Texas, 51 percent of Austin employers plan to add new full-time jobs.

Meanwhile, Houston leads the nation in plans to lure top talent. To attract new workers, 56 percent of Houston employers surveyed by Robert Half indicate they're handing out signing bonuses, versus 53 percent in Austin and 52 percent in Dallas. The same figure across the 28 cities in the survey was 48 percent.

"Hiring is happening across the board, and competition for talent is intensifying. Simultaneously, job seekers are becoming more discerning when evaluating opportunities," Paul McDonald, senior executive director at Robert Half, says in a news release. "With these two forces at play, employers need to exceed candidates' expectations or risk losing them to better offers."

This hiring surge comes amid substantial workforce turnover this year triggered in large part by the COVID-19 pandemic. Seventy-five percent of Houston employers say they've experienced increased turnover this year, compared with 80 percent in Austin and 71 percent in Dallas. Nationally, the same number was 73 percent.

"Professionals with in-demand skills often have their pick of jobs," McDonald says. "To stand the best chance of winning over top candidates, employers need to modernize and minimize role requirements, move quickly, and make the most competitive offer possible from the start."

------

This article originally ran on CultureMap.

Some 49 percent of Houston workers are burned out at work. Getty Images

Nearly half of Houston workers complain of serious burnout, says new report

working hard

Local workers who're especially dreading that commute or cracking open the laptop in the morning aren't alone. A new study reveals that nearly half of Houston laborers are more burned out on the job.

Some 49 percent of Bayou City residents report to be burned out at work, according to employment industry website Robert Half. That's significantly higher than last year, when only 37 percent reported burnout in a similar poll.

Meanwhile, more than one in four Houston workers (28 percent) say that they will not unplug from work when taking time off this summer.

Not surprisingly, American workers are ready for a vacation. Per a press release, the research also reveals:

  • One in four workers lost or gave up paid time off in 2020
  • One in three plans to take more than three weeks of vacation time this year

Elsewhere in Texas, the burnout is real. In Dallas, 50 percent of workers report serious burnout. More than a quarter — 26 percent — of Dallasites fear they won't disconnect from the office during summer vacation.

In fun-filled Austin, 45 percent of the workforce complain of burnout. Some 32 percent of Austinites feel they can unplug from work during the summer.

Fortunately for us, the most burned-out city in the U.S. isn't in the Lone Star State. That dubious title goes to the poor city of Charlotte, North Carolina, where 55 percent of laborers are truly worn out.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston medtech firm secures $30M for neurosurgical robot

stroke surgery

Robotic neurosurgery is an exciting new frontier in medicine, and Houston-based medtech firm XCath is leading the charge with its revolutionary Iris robotic system. The company announced in March that it had secured $30 million in Series C funding to continue developing systems to tackle blood clots in the human brain.

“We are grateful to our investors for their conviction in our shared mission to improve clinical outcomes for patients impacted by endovascular diseases,” Eduardo Fonseca, CEO of XCath, said in a news release. “In 2025, the XCath team advanced the frontiers of endovascular robotics. This funding accelerates our commitment to expanding access to life-saving care so that where a patient lives no longer determines whether they live.”

XCath–which also has campuses in Pangyo, South Korea–has already achieved a number of remarkable firsts in robotic neurosurgery. The Iris is the only endovascular robotic system currently in development to perform intracranial navigation or neurointerventional treatment, and is the only robot in the world to have performed an intracranial neurovascular procedure involving the robotic manipulation of three devices.

These new Series C funds, which bring the company's total investment to $92 million, will go toward developing a clinical telerobot capable of performing a mechanical thrombectomy. This would bring unprecedented accuracy and precision to the surgical removal of brain clots, significantly reducing the risk of neurosurgery.

“Robotic surgery succeeds when innovation is paired with practical execution,” Dr. Fred Moll, chairman of the XCath board of directors, said in the release. “XCath has built a promising technology foundation, and just as importantly, a team that values rigor and appreciates perspective. I’m excited to support them as they take on the mission of globalizing access to gold-standard care for stroke patients.”

In November 2025, the Iris debuted under the control of Dr. Vitor Mendes Pereira at The Panama Clinic in Panama City, alongside local Principal Investigator Dr. Anastasio Ameijeiras Sibauste. It was only the second time in human history that a robot had been used for intracranial neurovascular intervention, and it established Iris as a viable technology in the fight against stroke.

“Treatment of stroke and other neurovascular diseases represents one of the most significant financial opportunities in healthcare, supported by positive reimbursement dynamics and strong demand from health systems,” Nicholas Drysdale, CFO of XCath, added in the release. “With our continued investor support and disciplined capital deployment, XCath is positioned to build a category-leading platform in endovascular robotics”.

Houston geothermal unicorn Fervo officially files for IPO

going public

Fervo Energy has officially filed for IPO.

The Houston-based geothermal unicorn filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission on April 17 to list its Class A common stock on the Nasdaq exchange. Fervo intends to be listed under the ticker symbol "FRVO."

The number and price of the shares have not yet been determined, according to a news release from Fervo. J.P. Morgan, BofA Securities, RBC Capital Markets and Barclays are leading the offering.

The highly anticipated filing comes as Fervo readies its flagship Cape Station geothermal project to deliver its first power later this year

"Today, miles-long lines for gasoline have been replaced by lines for electricity. Tech companies compete for megawatts to claim AI market share. Manufacturers jockey for power to strengthen American industry. Utilities demand clean, firm electricity to stabilize the grid," Fervo CEO Tim Latimer shared in the filing. "Fervo is prepared to serve all of these customers. Not with complex, idiosyncratic projects but with a simplified, standardized product capable of delivering around-the-clock, carbon-free power using proven oil and gas technology."

Fervo has been preparing to file for IPO for months. Axios Pro first reported that the company "quietly" filed for an IPO in January and estimated it would be valued between $2 billion and $3 billion.

Fervo also closed $421 million in non-recourse debt financing for the first phase of Cape Station last month and raised a $462 million Series E in December. The company also announced the addition of four heavyweights to its board of directors last week, including Meg Whitman, former CEO of eBay, Hewlett-Packard, and Spring-based HPE.

Fervo reported a net loss of $70.5 million for the 2025 fiscal year in the S-1 filing and a loss of $41.1 million in 2024.

Tracxn.com estimates that Fervo has raised $1.12 billion over 12 funding rounds. The company was founded in 2017 by Latimer and CTO Jack Norbeck.

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

New UT Austin med center, anchored by MD Anderson, gets $1 billion gift

Future of Health

A donation announced Tuesday, April 21, breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release.

The release also records "significant support" for undergraduate scholarships, student housing, and the Texas Advanced Computing Center for supercomputing research.

Both the new research campus and the UT Dell Medical Center will integrate advanced computing into their research and practices. At the medical center, the university hopes that will lead to "earlier detection, more precise and personalized care, and better health outcomes." The University of Texas MD Anderson Cancer Center will also be integrated into the new medical center.

That comes with a numeric goal measured in 10s: raise $10 billion and rank among the top 10 medical centers in the U.S., both in the next decade.

In the shorter term, the university will break ground on the medical center with architecture firm Skidmore, Owings & Merrill (SOM) "later this year."

“UT Austin, where Dell Technologies was founded from a dorm room, has always been a place where bold ideas become real-world impact,” said Michael and Susan Dell in a joint statement.

They continued, “What makes this moment so meaningful is the opportunity to build something that brings every part of the journey together — from how students learn, to how discoveries are made, to how care reaches families. By bringing together medicine, science and computing in one campus designed for the AI era, UT can create more opportunity, deliver better outcomes, and build a stronger future for communities across Texas and beyond.”

This is the second major gift this year for the planned multibillion-dollar medical center. In January, Tench Coxe, a former venture capitalist who’s a major shareholder in chipmaking giant Nvidia, and Simone Coxe, co-founder and former CEO of the Blanc & Otus PR firm, contributed $100 million$100 million.

View All Listings